Related Experiment Video
Updated: Jul 1, 2025

Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
Published on: October 23, 2018
MTOR modulation induces selective perturbations in histone methylation which influence the anti-proliferative effects
HaEun Kim1,2, Benjamin Lebeau1,2,3, David Papadopoli2,4
1Department of Experimental Medicine, McGill University, Montreal, QC H3A 0G4, Canada.
Abstract:
Emerging data suggest a significant cross-talk between metabolic and epigenetic programs. However, the relationship between the mechanistic target of rapamycin (mTOR), which is a pivotal metabolic regulator, and epigenetic modifications remains poorly understood. Our results show that mTORC1 activation caused by the abrogation of its negative regulator tuberous sclerosis complex 2 (TSC2) coincides with increased levels of the histone modification H3K27me3 but not H3K4me3 or H3K9me3. This selective H3K27me3 induction was mediated via 4E-BP-dependent increase in EZH2 protein levels. Surprisingly, mTOR inhibition also selectively induced H3K27me3. This was independent of TSC2, and was paralleled by reduced EZH2 and increased EZH1 protein levels. Notably, the ability of mTOR inhibitors to induce H3K27me3 levels was positively correlated with their anti-proliferative effects. Collectively, our findings demonstrate that both activation and inhibition of mTOR selectively increase H3K27me3 by distinct mechanisms, whereby the induction of H3K27me3 may potentiate the anti-proliferative effects of mTOR inhibitors.
Insights
Mechanistic target of rapamycin (mTOR) pathway activation or inhibition selectively increases H3K27me3 histone modification. This epigenetic change, mediated by distinct mechanisms, may enhance the anti-proliferative effects of mTOR inhibitors.
Area of Science:
- Cellular Biology
- Epigenetics
- Molecular Biology
Background:
- Metabolic and epigenetic programs exhibit significant cross-talk.
- The mechanistic target of rapamycin (mTOR) pathway is a key metabolic regulator.
- The precise relationship between mTOR signaling and epigenetic modifications is not well understood.
Purpose of the Study:
- To investigate the impact of mTOR pathway modulation on specific histone modifications.
- To elucidate the mechanisms underlying changes in histone methylation.
- To explore the correlation between mTOR-induced epigenetic changes and anti-proliferative effects.
Main Methods:
- Analysis of histone modifications (H3K27me3, H3K4me3, H3K9me3) in response to mTORC1 activation (TSC2 abrogation) and inhibition.
- Assessment of EZH2 and EZH1 protein levels.
- Correlation analysis between H3K27me3 induction and anti-proliferative activity of mTOR inhibitors.
Main Results:
- mTORC1 activation selectively increased H3K27me3 levels, independent of H3K4me3 and H3K9me3, via increased EZH2.
- mTOR inhibition also selectively induced H3K27me3 through a mechanism involving reduced EZH2 and increased EZH1.
- The induction of H3K27me3 by mTOR inhibitors correlated positively with their anti-proliferative effects.
Conclusions:
- Both activation and inhibition of the mTOR pathway selectively increase H3K27me3 via distinct molecular mechanisms.
- The selective induction of H3K27me3 may contribute to the anti-proliferative efficacy of mTOR inhibitors.
- This study reveals a novel link between mTOR signaling and H3K27 trimethylation dynamics.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Abnormal Proliferation
Mitogens and the Cell Cycle
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Drugs that Stabilize Microtubules

